Sartorius (SRT) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
22 Oct, 2026Executive summary
9M 2026 revenue reached EUR 2,737.2m, with 8.1% operational growth excluding tariff compensation; both divisions contributed.
Underlying EBITDA rose 6.9% to EUR 827.8m and margin expanded to 30.2%; free cash flow increased 55.2% to EUR 310m as leverage declined.
Recurring consumables remained the main growth driver, while equipment sales continued recovering.
FY guidance was maintained for the Group and BPS; LPS margin guidance and the capex ratio outlook were refined.
Financial highlights
9M revenue was EUR 2,737.2m, up 4.9% reported, 6.9% in constant currencies including tariff compensation, and 8.1% operationally excluding it.
Underlying EBITDA increased 6.9% to EUR 827.8m; margin rose 0.5 percentage points to 30.2%.
Underlying net profit rose 6.7% to EUR 259.8m; underlying EPS was EUR 3.76 per ordinary share and EUR 3.77 per preference share.
Operating cash flow increased 9.9% to EUR 561.6m; free cash flow rose 55.2% to EUR 310.0m, supported by lower capex.
Q3 sales rose 9.9% reported to EUR 926.3m; underlying EBITDA increased 13.4% to EUR 279.9m, with a 30.2% margin.
Outlook and guidance
FY operational sales growth guidance remains 5%–9% for the Group and 6%–10% for BPS; expected performance is around the midpoint.
LPS sales growth is expected near the upper end of its guidance range; margin guidance rose to slightly above 21% from slightly below 21%.
Underlying EBITDA margin guidance remains slightly above 30% for the Group and 32% for BPS.
Group capex ratio guidance was refined to ~12% from ~12.5%; net debt to underlying EBITDA is expected slightly above 3x at year-end.
Forecasts reflect elevated industry volatility; potential additional U.S. tariff changes are excluded, and intended compensation could reduce Group revenue by up to EUR 40m.
Latest events from Sartorius
- Sales and margins rose in H1 2026, with guidance confirmed despite tariff impacts.SRT
Q2 2026 - Sales up 7.5% in Q1 2026, resilient margins, and 2026 guidance confirmed amid volatility.SRT
Q1 2026 - Strong growth, strategic investments, and a proposed dividend marked the AGM.SRT
AGM 2026 - Midterm targets: 8%-11% organic growth, margin expansion, and innovation-led portfolio focus.SRT
CMD 2026 - Strong sales and margin gains in 2025 support a positive outlook for 2026.SRT
Q4 2025 - Profitable growth with 7.5% sales increase, higher EBITDA margin, and raised guidance.SRT
Q3 2025 - Strong H1 2025 growth driven by recurring consumables and margin expansion; outlook reaffirmed.SRT
Q2 2025 - Order intake and cash flow rose, supporting stable sales and margins for 2024.SRT
Q3 2024 - 2024 sales and profitability held firm; strong Q4 and order recovery signal cautious optimism for 2025.SRT
Q4 2024